viral pathogens | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,241 results for “viral pathogens”

Trials

View all 2808 →

Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study

First posted Jun 1, 2022

Evaluation of Respiratory Specimens for Bacterial and Viral Pathogens by Real-Time PCR

867 participants · First posted Jan 12, 2006

Active, not recruiting

Bio-reconfigurable Electronic Platform for Multiplex Detection of Viral Respiratory Pathogens

158 participants · First posted Nov 25, 2024

Drugs

View all 213 →

anti-viral compound

HEP-viral

double viral vaccine

Organizations

View all 35 →

AlloVir

United States

Frantz Viral Therapeutics, LLC

United States

VIETNAM VIRAL HEPATITIS ALLIANCE

United States

News

View all 2185 →

FDA Grants Emergency Use Authorization to Seegene's Allplex Multiplex PCR Assay for Simultaneous Detection of Four Viral Pathogens

Israeli Scientists Develop First mRNA Vaccine Against Bacterial Infection, Targeting Plague Pathogen

Kling Bio Partners with Sanofi to Develop Next-Generation Antiviral Antibodies Using Proprietary B Cell Platform

Page 1 of 525